Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by KENDALL, R.
Right arrow Articles by PULLAR, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by KENDALL, R.
Right arrow Articles by PULLAR, T.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1993 British Society for Rheumatology

research-article

THE RELATIONSHIP OF HAEMOGLOBIN TO SERUM ERYTHROPOIETIN CONCENTRATIONS IN THE ANAEMIA OF RHEUMATOID ARTHRITIS: THE EFFECT OF ORAL PREDNISOLONE

R. KENDALL, A. WASTI{ddagger}, A. HARVEY{ddagger}, J. HILL{ddagger}, C. CHAPMAN*, D. R. NORFOLK and T. PULLAR{dagger},{ddagger},

Departments of Haematology Harrogate
*Chemical Pathology, Royal Bath Hospital Harrogate
{dagger}Medicine of the General Infirmary at Leeds, Royal Bath Hospital Harrogate
{ddagger}The Clinical Pharmacology Unit (Rheumatism Research), Royal Bath Hospital Harrogate

Correspondence to: Correspondence to T. Pullar, Wards 1&2, Ninewells Hospital, Dundee

Previous studies of the erythropoietin response to anaemia in RA have yielded conflicting findings. Some have found the response to be impaired and others have found a normal response. We have compared erythropoietin (EPO) levels measured by radioimmunoassay, in 54 anaemic rheumatoid patients and 55 patients with iron deficiency anaemia but no inflammatory disease.

The erythropoietin response in the rheumatoid patients was impaired compared with the control group (P < 0.025) but only seven rheumatoid patients showed a response which fell below the 95% confidence intervals predicted for the control group. Rheumatoid patients who fell within the highest quartile for serum ferritin concentrations (i.e. those most likely to have anaemia of chronic disease) had significantly lower EPO levels compared with the control group (P < 0.01). EPO levels in rheumatoid patients within the lowest quartile for ferritin (i.e. those with iron deficiency anaemia) were not significantly different from the control group (P = 0.670). The difference in EPO response between the RA patients in the upper and lower quartile for ferritin approached but did not achieve significance (P = 0.056). In a second study 15 anaemic RA patients were given a 5-day course of oral prednisolone 1.5 mgkg-1. Haemoglobin did not rise significantly until day 4 but EPO levels fell by day 1 (P < 0.005) and remained lower than pretreatment values throughout the study. Thus, in RA patients, anaemia of chronic disease is associated with inappropriately low EPO concentrations but this does not appear to be the major cause of the anaemia and Hb response to prednisolone does not depend upon an increase in EPO concentration.

KEY WORDS: Rheumatoid arthritis, Anaemia of chronic disease, Erythropoietin, Prednisolone


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.